The Antinitus patch is worn behind the ear and its developers, Sensori AB, claim it can help reduce the discomfort of tinnitus. The developers state that the patch works by reorganising water in the ‘biological environment’ to help relieve the ‘chaotic audio loops’ that represent tinnitus.

Physicians at the Sickla ENT-centre in Stockholm and the Citysjukhuset hospital in Gothenburg conducted a double-blind, randomised, parallel and placebo-controlled study of Antinitus in 2016/2017.

The study involved 82 patients and was designed to compare the clinical effects of Antinitus with a placebo. Results of the study showed that as many patients in the Antinitus group experienced relief from tinnitus compared to the placebo group. Side effects of the patch mainly included skin irritations.

The study has been published in the International Tinnitus Journal.

Speaking about the results, Torbjörn Kemper, managing director of Sensori AB, said: “The publication in the International Tinnitus Journal means that the placebo study has been critically reviewed by leading and independent scientific experts in the field of tinnitus. The result of the study, and its review, is a great leap forward for Sensori, but primarily positive news for all the people around the world who are living with tinnitus. With Antinitus, they can choose a solution and treatment that show good opportunities for relief and an increased quality of life.”

Tommy Rönngren, founder and Member of the Board at Sensori AB, said: “The interest in and publication of the study opens up an assertive global commercialisation of the tinnitus patch and Sensori. This is something that our potential partners/distributors have been waiting for, but above all, I am incredibly proud that we, as a Swedish company, have, after years of product development, developed a tinnitus product with high clinical evidence that can help many of the millions of people suffering from tinnitus worldwide”.